These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31311301)

  • 21. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
    Li T; Huang X; Yue Z; Meng L; Hu Y
    Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.
    Yuan X; Li Y; Wen S; Xu C; Wang C; He Y; Zhou L
    Lipids Health Dis; 2022 Nov; 21(1):127. PubMed ID: 36443854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous hydrogen sulfide alleviates hepatic endoplasmic reticulum stress via SIRT1/FoxO1/PCSK9 pathway in NAFLD.
    Cui X; Yao M; Feng Y; Li C; Li Y; Guo D; He S
    FASEB J; 2023 Aug; 37(8):e23027. PubMed ID: 37410029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling.
    Sun Y; Song Y; Liu C; Geng J
    Biochem Biophys Res Commun; 2019 Aug; 516(2):584-590. PubMed ID: 31239155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
    Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
    Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway.
    Zhang W; Sun Y; Liu W; Dong J; Chen J
    Int J Mol Med; 2019 Mar; 43(3):1271-1280. PubMed ID: 30664220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptotanshinone from the
    Nagappan A; Kim JH; Jung DY; Jung MH
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice.
    Xiong X; Wang X; Lu Y; Wang E; Zhang Z; Yang J; Zhang H; Li X
    J Hepatol; 2014 Apr; 60(4):847-54. PubMed ID: 24333182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipocytes-derived exosomal miR-122 promotes non-alcoholic fat liver disease progression via targeting Sirt1.
    Chen K; Lin T; Yao W; Chen X; Xiong X; Huang Z
    Gastroenterol Hepatol; 2023; 46(7):531-541. PubMed ID: 36584755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA Gm28382 promotes lipogenesis by interacting with miR-326-3p to regulate ChREBP signaling pathway in NAFLD.
    Yang S; Zhang Y; Zhang Y; Yin L; Han X; Zhao X; Wang N; Xu L
    Int Immunopharmacol; 2024 Jan; 127():111444. PubMed ID: 38157698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
    Sodhi K; Puri N; Favero G; Stevens S; Meadows C; Abraham NG; Rezzani R; Ansinelli H; Lebovics E; Shapiro JI
    PLoS One; 2015; 10(6):e0128648. PubMed ID: 26098879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy.
    Stacchiotti A; Grossi I; García-Gómez R; Patel GA; Salvi A; Lavazza A; De Petro G; Monsalve M; Rezzani R
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD.
    Di Mauro S; Salomone F; Scamporrino A; Filippello A; Morisco F; Guido M; Lembo V; Cossiga V; Pipitone RM; Grimaudo S; Malaguarnera R; Purrello F; Piro S
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK/autophagy- and AMPK/ORP150-mediated signaling.
    Pyun DH; Kim TJ; Kim MJ; Hong SA; Abd El-Aty AM; Jeong JH; Jung TW
    J Cell Physiol; 2021 Jul; 236(7):4902-4912. PubMed ID: 33283879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway.
    Chen Z; Liu Y; Yang L; Liu P; Zhang Y; Wang X
    Immunol Lett; 2020 Jun; 222():40-48. PubMed ID: 32194141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.
    Ao R; Wang Y; Tong J; Wang BF
    Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.